Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity

Cancer immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced cancers. However, the tumor microenvironment (TME) functions as a formidable barrier that severely impairs the efficacy of ICIs. While the crosstalk between tumor vessels and immune cells deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Won Suk, Yang, Hannah, Chon, Hong Jae, Kim, Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080646/
https://www.ncbi.nlm.nih.gov/pubmed/32913278
http://dx.doi.org/10.1038/s12276-020-00500-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080646/
https://www.ncbi.nlm.nih.gov/pubmed/32913278
http://dx.doi.org/10.1038/s12276-020-00500-y

Ejemplares similares